DMD and Duchenne muscular dystrophy: The adverse-event profile and local dystrophin-restoring effect of a single intramuscular injection of an antisense 2'-O-methyl phosphorothioate oligonucleotide, PRO051/GSK2402964, in patients with DMD were explored [12].